Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-01-13 @ 11:33 AM
Study NCT ID:
NCT00232661
Status:
COMPLETED
Last Update Posted:
2010-02-03
First Post:
2005-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PROACT - Pre-Operative Arimidex Compared To Tamoxifen
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1033IL/0039
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Francisco Sapunar, MD - Arimidex Medical Science Director
Old Organization:
AstraZeneca